Trials / Completed
CompletedNCT02498873
Linear Running Periodization x Nonlinear
Linear Running Periodization x Nonlinear: a Cross Effect of Five Months Controlled Running on VO2Max and Critical Power Performance
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 35 (actual)
- Sponsor
- Universidade Federal do Rio de Janeiro · Academic / Other
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
In a competitive scenario, trainers and coaches seek to improve the performance of their athletes organizing macrocycles (year), mesocycles (months), and microcycles (weeks) training aimed at a specific moment of a competition. The organization variables, mainly the intensity of exercise in a training routine can stimulate important physiological pathways and uphold superior gains to VO2max, leading to a peak aerobic performance. However, due to lack of evidence, and the difficulty of control on a large scale, the effects of the intensity organization over a mesocycle periodization are still poorly investigated.
Detailed description
The objective of this study is compare two intensity blocks organization a) linear progression intensity (LP) and b) randomized or not intensity linaer (NLP) over five months running training, and a crossover design between subjects, on gains in VO2max, peak velocity (Vpeak) and critical power (CP). Furthermore, the relationship between the gains obtained with the training and the amount of exercise will be established. In our case all dependent variables will increase after training, with no significant differences between the two strategies on dependent variables.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Linear Periodization | Linear Intensity Periodization Running |
| BEHAVIORAL | Non Linear Periodization | Non Linear Periodization Running |
Timeline
- Start date
- 2015-08-01
- Primary completion
- 2015-12-01
- Completion
- 2016-01-01
- First posted
- 2015-07-15
- Last updated
- 2016-01-20
Source: ClinicalTrials.gov record NCT02498873. Inclusion in this directory is not an endorsement.